LPM-526000133

N/A

Report date: 2025/12/29 09:41:28
NME

Base Information

Drug NameLPM-526000133
Drug Alias NameLPM526000133LPM-526000133LY03017LY-03017LPM526000133 Fumarate
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSerotonin 2a (5-HT2a) receptor inverse agonistsSerotonin 2a (5-HT2a) receptor antagonists
TargetsSerotonin 2a (5-HT2a) receptor
Therapy Area/IndicationsSchizophreniaDelusionsHallucinations +[5
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesMainland China
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaPhase 2 Clinical
Originator CompaniesLuye Pharma Group Ltd
China Registration ClassClass 1 Chemical Drug in China

Develop Information

Inactive CompaniesN/A
Active IndicationsSchizophreniaDelusionsHallucinations +[5
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A